Philip Morris pm stock Falls 0.9% Despite 50% Year-to-Date Surge Amid Mixed Earnings

Generated by AI AgentWord on the Street
Tuesday, Jul 22, 2025 11:04 am ET1min read
PM--
Aime RobotAime Summary

- Philip Morris reported Q2 adjusted EPS of $1.91, exceeding 2023's $1.59 and analyst forecasts, with $10.14B revenue (up 7.1% YoY but below $10.33B estimates).

- Despite 50% YTD stock gains, shares fell 0.9% this quarter, while analysts raised EPS estimates by 3.2% but issued one downward revision amid mixed results.

- Smoke-free products now account for 41% of revenue (driven by Zyn and IQOS), though Zyn shipments declined for the first time, raising growth concerns.

- Company raised full-year profit guidance to $7.56/share but faced 9% early trading drop as investors weighed smoke-free segment challenges.

Philip Morris International Inc. (PM) has reported adjusted earnings of $1.91 per share for the quarter ending June 30, surpassing the previous year's figure of $1.59 and also beating the consensus forecast of $1.86 by fifteen analysts. The reported EPS for the quarter was slightly higher at $1.95. Revenue for the quarter grew by 7.1% year-over-year to $10.14 billion, although it fell short of the $10.33 billion expected by analysts. The company posted a net income of $3.04 billion.

Despite exceeding earnings expectations, Philip MorrisPM-- shares experienced a downtrend, slipping by 0.9% this quarter, though they have shown an impressive 50% increase year-to-date. Analysts have reacted to the developments by adjusting their earnings estimates, with the mean estimate rising by about 3.2% over the last three months. Nevertheless, one analyst issued a downward revision in the previous 30 days, reflecting some caution within the analyst community.

Philip Morris continues to garner positive sentiment from Wall Street, with an average analyst rating classified as "buy." Among the breakdown, 12 analysts have offered a "strong buy" or "buy" rating, while six have provided a "hold" rating. Notably, no analysts have rendered a "sell" or "strong sell" recommendation. The consensus price target over the next 12 months stands at $186, marking a potential 3% increase over the latest closing price of $180.48.

The earnings report highlighted a notable development in the company's smoke-free segment, which now represents 41% of the overall revenue, primarily driven by the popular Zyn pouches and the IQOS heated tobacco product. However, the quarter marked the first decline in shipments for Zyn, a concerning trend that may raise questions about the future growth potential of this segment.

Philip Morris acknowledged the softness in revenue expectations for the quarter by reporting $10.1 billion in sales, below analysts' expectations of $10.3 billion. Yet, the company remains optimistic, increasing its full-year profit guidance to as high as $7.56 this year, up from a prior cap of $7.49. Despite outperforming major indices in a broader market environment fraught with tariff and recession concerns, Philip Morris shares fell by 9% in early trading as investors digested the mixed results and considered the challenges faced in its smoke-free strategic focus.

Stay ahead with real-time Wall Street scoops.

Latest Articles

Stay ahead of the market.

Get curated U.S. market news, insights and key dates delivered to your inbox.

Comments



Add a public comment...
No comments

No comments yet